MedPath

Dismembered Pyeloplasty With and Without After Coming Stent

Not Applicable
Completed
Conditions
Pyeloplasty
Pelviureteric Junction Obstruction
Obstructive Uropathy
Urinary Stent
Neonatal Hydronephrosis
Registration Number
NCT02138877
Lead Sponsor
Cairo University
Brief Summary

to compare outcome of pyeloplasty in pediatric population less than 6 months in age using an after coming stent versus stentless pyeloplasty.

Detailed Description

A prospective randomized control study including patients divided into two groups,all patient undergoes dismembered pyeloplasty First group will be with an after coming stent ,Second group will be stentless to compare outcome of pyeloplasty in pediatric population less than 6 months in age

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Pelvi-ureteric junction obstruction (PUJO)
  • Asymptomatic obstruction with reduced function (less than 35-40%)
  • Asymptomatic obstruction with antero-posterior diameter exceed 40 mm
  • Asymptomatic obstruction with deterioration on conservative follow up.
  • Symptomatic PUJ obstruction, e.g. pain, renal mass, fever and stones.
Exclusion Criteria
  • Secondary Pelvi-ureteric junction obstruction
  • Solitary kidney
  • Gross pyuria
  • Ectopic kidney
  • Dilated ureter

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Postoperative Hospital stay1 week

Postoperative Hospital stay

Fever1 month

Postoperative fever

Leakage1 week

occurrence of post operative leakage

2ry intervention1 month

Need for 2ry intervention in the form of insertion of ureteral stent

Secondary Outcome Measures
NameTimeMethod
success6 months

Need for 2ry treatment of persistent pelviureteric junction obstruction

Assessment of kidney function after repair6 months

- Assessment of kidney function after repair using renogram and ultrasound

Trial Locations

Locations (1)

Cairo University Hospitals

🇪🇬

Cairo, Egypt

Cairo University Hospitals
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.